The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells

BACKGROUND: Despite multimodal treatment, glioblastoma (GBM) therapy with temozolomide (TMZ) remains inefficient due to chemoresistance. Matrix metalloproteinase (MMP) and a disintegrin and metalloprotease (ADAM), increased in GBM, could contribute to chemoresistance and TMZ-induced recurrence of gl...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Dong, Fangyong, Eibach, Michael, Bartsch, Jörg W., Dolga, Amalia M., Schlomann, Uwe, Conrad, Catharina, Schieber, Susanne, Schilling, Oliver, Biniossek, Martin L., Culmsee, Carsten, Strik, Herwig, Koller, Garrit, Carl, Barbara, Nimsky, Christopher
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2015
Onderwerpen:
Basic and Translational Investigations
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4648299/
https://ncbi.nlm.nih.gov/pubmed/25825051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov042
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items